JRCT ID: jRCT1030240477
Registered date:11/11/2024
Scoring systems for predicting genotype-matched clinical trial enrollment rates after CGP testing
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Solid tumors |
Date of first enrollment | 01/02/2024 |
Target sample size | 150 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Primary endpoint: Comparison of AUC between the scoring system prediction and referring physicians' prediction |
---|---|
Secondary Outcome | Secondary endpoint: Comparison of AUC based on referring physicians' experience with CGP testing |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1. Physicians who performed cancer gene panel testing 2. Physicians who referred patients to National Cancer Center Hospital for clinical trials matched to genetic alterations |
Exclude criteria | Physicians deemed inappropriate by the Principal Investigator |
Related Information
Primary Sponsor | Koyama Takafumi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Yuji Uehara |
Address | 5 Chome-1-1 Tsukiji, Chuo City, Tokyo 104-0045 Tokyo Japan 104-0045 |
Telephone | +81-3-3542-2511 |
yuueha2@ncc.go.jp | |
Affiliation | National Cancer Center Hospital, Department of Experimental Therapeutics |
Scientific contact | |
Name | Takafumi Koyama |
Address | 5 Chome-1-1 Tsukiji, Chuo City, Tokyo 104-0045 Tokyo Japan 104-0045 |
Telephone | +81-3-3542-2511 |
takoyama@ncc.go.jp | |
Affiliation | National Cancer Center Hospital, Department of Experimental Therapeutics |